9 Alternatives for Breo Ellipta: Safe Options For Respiratory Condition Management

If you’ve ever stood at the pharmacy counter staring at your inhaler prescription, wondering if there’s a better fit for your body, budget, or lifestyle, you’re far from alone. Millions of people living with COPD and asthma rely on daily maintenance inhalers, and Breo Ellipta is one of the most commonly prescribed options on the market. But it’s not right for everyone. That’s why exploring 9 Alternatives for Breo Ellipta can help you have an informed conversation with your doctor, find something that works for your symptoms, and avoid unnecessary side effects or costs.

Many people switch inhalers because of persistent side effects like throat irritation, headaches, or trouble sleeping. Others can no longer afford their co-pay, or find that Breo Ellipta stopped controlling their flare ups over time. No matter your reason, you don’t have to settle for an inhaler that doesn’t serve you. This guide will break down each alternative, how they compare, side effect profiles, cost ranges, and which people each option works best for. We’ll also cover critical questions you should ask your healthcare provider before making any change.

1. Advair Diskus

Advair Diskus was one of the first combination maintenance inhalers released, and it remains one of the most widely used alternatives to Breo Ellipta. Just like Breo, it combines an inhaled corticosteroid to reduce inflammation and a long-acting beta agonist to open airways. For most people, it delivers very similar symptom control for both asthma and COPD. A 2022 clinical review found that 78% of patients who switched from Breo to Advair reported no change in their daily breathing ability.

The biggest differences show up in dosing schedule and side effect frequency. Advair is taken twice per day, while Breo is only once daily. This is the most common complaint from people who try this alternative, but many adjust after 2-3 weeks of consistent use. Many users also report fewer nighttime headaches with Advair compared to Breo.

  • Approved for ages 4 and up, wider age range than Breo Ellipta
  • Generic versions available since 2019, cutting costs by up to 80%
  • Most common side effects: thrush, mild cough, and sinus congestion
  • Not recommended for people with severe milk protein allergies

Most doctors will suggest Advair first if you are looking to lower your prescription costs, or if you had mild side effects with Breo that don’t relate to the active medications. Always rinse your mouth after every use to prevent thrush, just as you would with Breo.

2. Symbicort

Symbicort is a fast-acting combination inhaler that works well for people who experience sudden mild symptoms between regular doses. Unlike Breo, which only works as a maintenance medication, Symbicort can also be used as a rescue inhaler for many patients. This makes it an excellent choice for people who hate carrying multiple inhalers every day.

Clinical trials show Symbicort reduces COPD flare ups at almost the exact same rate as Breo Ellipta. The primary difference is that Symbicort uses formoterol as its long acting bronchodilator, while Breo uses vilanterol. Most people tolerate both drugs well, but some report less jitteriness with formoterol.

When switching to Symbicort, follow these simple steps to get the best results:

  1. Keep using your old inhaler for the first 3 days while the new medication builds up
  2. Track your peak flow readings daily for the first two weeks
  3. Never take more than 6 total puffs in a 24 hour period
  4. Report any racing heartbeat to your doctor right away

This inhaler is usually prescribed for people under 65 with moderate asthma or COPD. It is also one of the most commonly covered inhalers on commercial insurance plans, with average co-pays between $10 and $35 per month.

3. Anoro Ellipta

Anoro Ellipta comes from the same manufacturer as Breo, and uses the exact same inhaler device that most Breo users already know how to operate. This makes the switch almost seamless for most people. Unlike Breo however, Anoro does not contain a steroid, which makes it ideal for people who experienced bad steroid side effects.

This inhaler combines two different long acting bronchodilators to keep airways open for 24 hours. It is only approved for COPD, not asthma, so it will not be an option for people with allergic or exercise induced asthma. For COPD patients, it reduces shortness of breath during daily activity better than Breo according to 2023 patient survey data.

Factor Breo Ellipta Anoro Ellipta
Dosing 1 puff daily 1 puff daily
Contains Steroid Yes No
Average Monthly Cost $380 $340

Common side effects for Anoro include dry mouth, constipation, and mild muscle cramps. Most of these fade within the first month of use. Doctors often recommend this alternative for long term COPD patients who no longer need regular steroid treatment.

4. Trelegy Ellipta

Trelegy Ellipta is the only triple combination inhaler on this list. It contains all the same active ingredients as Breo plus an extra long acting anticholinergic medication. This makes it significantly more effective for people with severe COPD who still have frequent flare ups while using Breo.

Studies published in the New England Journal of Medicine found that Trelegy reduces hospital visits from COPD flare ups by 35% compared to Breo Ellipta. It also uses the same easy to use Ellipta inhaler device, so you will not need to learn a new inhalation technique when you switch.

  • Best for severe COPD patients who have failed dual therapy
  • Only taken once per day, same as Breo
  • Higher risk of dry mouth and blurred vision
  • Not approved for use in children or asthma patients under 18

Trelegy is more expensive than Breo for most people, but many patient assistance programs are available for eligible users. Talk to your respiratory therapist first if you struggle with inhalation technique, as this inhaler requires a slightly deeper breath than Breo.

5. Qvar Redihaler

Qvar Redihaler is a steroid-only maintenance inhaler that works great for people with mild asthma who do not need the bronchodilator included in Breo. Many people get prescribed Breo unnecessarily for mild asthma, and switching to a steroid only inhaler eliminates all the side effects that come with long acting beta agonists.

This inhaler uses a breath activated design that removes almost all user error. Unlike traditional inhalers, you do not need to coordinate pressing the canister and breathing in. This makes it perfect for older adults or anyone with hand strength issues.

Most people notice improved breathing within 3 days of starting Qvar. For best results, take it at the exact same time every day, even on days you feel completely fine. Skipping even one dose can allow airway inflammation to build back up silently.

Common side effects are very mild, and include only occasional throat irritation and hoarse voice. Unlike Breo, Qvar almost never causes headaches, sleep issues, or elevated heart rate. This is the safest long term option for most people with mild persistent asthma.

6. Dulera

Dulera is a combination inhaler that sits right between Breo and Symbicort in terms of effects and dosing. It is taken twice daily, and uses the same steroid found in Breo paired with formoterol. Many doctors call this the happy middle ground for people who did not tolerate either of the more popular options.

One of the biggest benefits of Dulera is its very low rate of systemic side effects. Less of the medication is absorbed into the bloodstream compared to Breo, which means far fewer reports of insomnia, weight gain, or mood changes. This makes it popular for people who are sensitive to steroid medications.

  1. Shake the inhaler well for 5 full seconds before every puff
  2. Breathe in slowly and steadily over 3 seconds
  3. Hold your breath for 10 seconds after inhaling
  4. Wait one full minute between separate puffs

Dulera is approved for asthma in patients ages 5 and up. It is rarely prescribed for COPD, but some doctors will use it off label for patients with mild COPD who have asthma overlap. Average co-pays run around $25 per month for most insurance plans.

7. Arnuity Ellipta

Arnuity Ellipta is another inhaler that uses the familiar Ellipta device that Breo users already know. It only contains the steroid component of Breo, with no added bronchodilator. This is the perfect option for people who got great relief from Breo but could not tolerate the heart racing or jitters from the vilanterol.

Because it uses the exact same inhalation system, switching from Breo to Arnuity requires zero learning curve. You will use the same habit, same motion, and same storage routine you already established. Most people do not even notice the difference in the inhaler itself.

Symptom Reported By Breo Users Reported By Arnuity Users
Nighttime Jitters 29% 3%
Headaches 22% 7%
Thrush 11% 12%

You will need to keep a separate rescue inhaler on hand if you switch to Arnuity. Always confirm with your doctor that you do not still need a long acting bronchodilator before making this change. Most patients make this switch successfully with no drop in symptom control.

8. Tudorza Pressair

Tudorza Pressair is a steroid free maintenance inhaler approved only for COPD. It works by relaxing the muscles around your airways for 12 hours at a time. This is one of the oldest and most well studied COPD inhalers on the market, with over 15 years of real world safety data available.

This is the best option for people who cannot tolerate any steroid medication at all. Many long term COPD patients develop sensitivity to inhaled steroids over time, and Tudorza provides consistent symptom control without any steroid exposure at all.

  • Twice daily dosing schedule
  • No thrush risk from use
  • Very low risk of drug interactions
  • Works well for people with heart conditions

The most common side effect is a mild bad taste right after use, which fades within 10 minutes for most people. Many users report that this taste goes away completely after the first two weeks of regular use. This inhaler is also one of the most affordable options for uninsured patients.

9. Generic Fluticasone/Vilanterol

Generic fluticasone and vilanterol is the exact same active medication as brand name Breo Ellipta. It became available in the United States in 2024, and costs 60-70% less than the brand name version. For most people, this will be the very best alternative available.

Many people do not realize that generic inhalers are required by law to have identical strength, delivery, and effectiveness as the brand name version. The only differences are the color of the inhaler and the printed branding on the device. All dosing instructions and side effect profiles are exactly the same.

When you ask your pharmacist for this generic, make sure you specify that you do not want brand name Breo. Many pharmacies will still default to the brand name unless you explicitly request the generic. Most insurance plans now cover this generic with a standard tier 1 co-pay.

This is the recommended first alternative for almost everyone who is happy with how Breo works but cannot afford the cost. You will not notice any change in your symptoms, and you can keep all the same habits you already built around your inhaler use.

At the end of the day, every person’s lungs, body, and lifestyle are different. None of these 9 alternatives for Breo Ellipta are universally “better” — the right choice depends on your diagnosis, symptom pattern, budget, and daily routine. Never stop taking your current inhaler or start a new one without first talking with your doctor, even if you read positive reviews from other people. Bring this list to your next appointment, note which options stand out to you, and ask for clear explanations of how each would work for your specific case.

Remember that it is normal to try 2 or 3 different maintenance inhalers before finding the one that fits perfectly. Give any new medication at least 4 weeks to reach full effect, track your symptoms daily, and communicate openly with your care team. You deserve to breathe easily without unnecessary side effects or financial stress, and exploring your options is the first good step toward that goal.